Enovix (ENVX) Research & Development (2020 - 2026)

Enovix has reported Research & Development for 7 years, with the latest figure at $26.5 million in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 2.31% year-over-year to $26.5 million; the trailing twelve-month figure through Apr 2026 stood at $110.9 million (up 9.13% YoY), and the FY2025 full-year result was $110.3 million, down 11.38% from the prior year.
• Research & Development for Q2 2026 stood at $26.5 million, down from $28.1 million in the prior quarter.
• The five-year high for Research & Development was $48.8 million in Q1 2024, with the low at $12.7 million in Q2 2022.
• Historically, Research & Development has averaged $25.0 million across 5 years, with a median of $25.9 million in 2025.
• Annual changes were most pronounced in 2022 — Research & Development jumped 127.79% — and 2025, when it tumbled 46.85%.
• Enovix's Research & Development stood at $13.9 million in 2022, then jumped by 147.94% to $34.6 million in 2023, then tumbled by 35.13% to $22.4 million in 2024, then advanced by 25.15% to $28.1 million in 2025, then declined by 5.51% to $26.5 million in 2026.
• The last three Research & Development figures came in at $26.5 million (Q2 2026), $28.1 million (Q4 2025), and $28.2 million (Q3 2025), per Business Quant data.